George Cardoza

George Cardoza (finance chief) discloses dealings in 2 companies, chiefly SOPHiA GENETICS SA and Neogenomics Inc. Over a trading history stretching from 2 June 2021 to 5 October 2026, the count stands at 15 filings.

Both buying and selling appear: 1 purchase worth €85k, against 9 sales worth €5.7M. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 5 share grants. Since January 2026: 1 purchase and 8 sales on the market.

The record was last updated on 7 October 2026 with an open-market sale (€11k) in SOPHiA GENETICS SA. The clock since the last published purchase (5 June 2026) now reads 135 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.